The Big Idea
Dr. Thomas Seyfried posits that all cancers share a common pathophysiological defect: damaged mitochondrial oxidative phosphorylation that forces reliance on glucose and glutamine fermentation. Effective metabolic therapy restricts these dual energy sources simultaneously through a ketogenic diet to lower blood glucose alongside targeted pharmacological or pulse therapies to suppress glutamine. This dual restriction starves fermentation-dependent cancer cells while transitioning healthy cells to rely on ketone bodies.
